DePuy Synthes launches degenerative spine disease implant platform

Eric Oliver -   Print  |

DePuy Synthes launched its new Conduit Interbody Platform at the North American Spine Society meeting, Sept. 25-28 in Chicago.

Surgeons can use the platform to treat degenerative spinal diseases. The platform features 3D-printed implants for spinal fusion surgery.

Wilson Ray, MD, used the platform in both the lumbar and cervical spine. He spoke highly of it, saying, "The implant allows for superior visualization, virtually no scatter on CT scan and early fusion assessment as compared to other titanium interbody devices."

Johnson & Johnson, DePuy's parent company, said the Conduit Platform reaffirms the company's commitment to 3D-printed technologies.

More articles on surface technology: 
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers